Current evidence linking the microbiome-gut-brain axis to glioma development, progression, and treatment response is summarized, highlighting findings from human studies, preclinical models, and recent mechanistic investigations.
Oscar Alcantar, A. Dono, Angel Bueno et al.· Hematology/Oncology Clinics...· 0 citations
The utility of ctDNA, particularly CSF ctDNA, as a complementary diagnostic tool in neuro-oncology is supported, with a promising performance of ctDNA analysis in patients with diffuse gliomas as a liquid biopsy strategy.
Christian Amezquita-Contreras, Angel Bueno, Diego Z. Arellano et al.· Neuro-Oncology Advances· 0 citations
A retrospective multi-institutional cohort study including 296 patients from 13 centers, SRS achieved durable long-term control with favorable survival and low incidence of visual and endocrinologic dysfunction.
A. Niranjan, J. Reyes, Constantinos G. Hadjipanayis et al.· Journal of Neuro-Oncology· 1 citation
With gravity-based retraction, modern navigation, and functional mapping, DMFC lesions can be resected more safely than in the past and support redefining SMA syndrome and expanding the role of mapping-guided resections in this region.
A. Dono, Shalin Shah, Maria Morkas et al.· Journal of Neurosurgery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.